RxDoctor Payments Data

James Brown, MD

Family Medicine · Coshocton, OHNPI 1013993716

Payments from drug & device makers

$265in general payments, 2019–2025

Across 15 payments — averaging $17.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Dexcom, Inc.$44
  • AbbVie$37
  • Exact Sciences$35
  • Astellas Pharma US Inc$32
  • Edwards Lifesciences$23
  • GSK$22
  • plus $73 from 5 others

What the payments were for

  • Food & beverage$265100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$265 in reported general payments places this provider in the 40th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$2,961
Medicare patients
102
Services billed
439

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide135$143,602
EliquisApixaban86$83,234
TrulicityDulaglutide62$71,897
JanuviaSitagliptin Phosphate55$49,130
JardianceEmpagliflozin45$43,519
FarxigaDapagliflozin Propanediol49$35,641
XareltoRivaroxaban24$29,291
Trelegy ElliptaFluticasone/Umeclidin/Vilanter29$21,841
Spiriva RespimatTiotropium Bromide35$21,480
MounjaroTirzepatide20$21,242
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr33$16,521
Nurtec OdtRimegepant Sulfate14$15,732
Lantus SolostarInsulin Glargine,hum.Rec.Anlog105$14,672
Breztri AerosphereBudesonide/Glycopyr/Formoterol23$14,614
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog13$11,243

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Nurtec Odt$13$98,966100 claims
AstraZenecaFarxiga, Breztri Aerosphere$14$50,25572 claims
GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta$22$49,41080 claims
Astellas Pharma US IncMyrbetriq$32$5,84113 claims
AbbVieSynthroid$37$1,61236 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Coshocton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →